CIK: 0001590144
Total reported value
$14.9M
Reporting period: 2026-03-31 · Number of holdings: 17
PURA VIDA INVESTMENTS, LLC disclosed 17 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $14.9M and a quarterly turnover rate of 58.4%.
Browse other institutions with under $100M AUMBrowse other institutions starting with "P"
Pura Vida Investments, LLC's disclosed holdings carry a Herfindahl concentration index of 0.130 — mathematically equivalent to about 8 equally-sized positions, well below its 17 actual disclosed holdings. That gap points to a strategy built around a small core of high-conviction bets rather than broad diversification.
Position sizes are fairly uniform across the portfolio (a coefficient of variation of 1.13), suggesting a disciplined, rules-based approach to how much capital goes into each idea.
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
Sector classification currently covers about 23% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Trim BBNX
0.0% -$5.8M
Trim IMDX
0.0% -$4.0M
Add G31249108
0.0% -$724.5K
Add NSPR
0.0% -$67.6K
Add CAI
0.0% -$818.5K
Add NVDA
+7.3% $1.5K
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | IMDX | Insight Molecular Diagnostic | Stock-Other | 20.88% | -5.67% | — | |
| 2 | BBNX | Beta Bionics INC | Stock-Other | 18.94% | -13.09% | — | |
| 3 | ✓ | Establishment Labs Hldgs INC | Stock-Other | 17.17% | +4.91% | — | |
| 4 | CAI | Caris Life Sciences INC | Stock-Other | 10.81% | +1.74% | — | |
| 5 | NSPR | Inspiremd INC | Stock-Other | 4.94% | +1.94% | — | |
| 6 | NTRA | Natera INC | Stock-Healthcare | 3.36% | +1.22% | — | |
| 7 | NVDA | Nvidia CORP | Stock-Tech | 2.93% | +1.31% | +7.30% | |
| 8 | JPM | Jpmorgan Chase & Co | Stock-Financials | 2.67% | +1.04% | — | |
| 9 | MSFT | Microsoft CORP | Stock-Tech | 2.46% | +0.29% | -17.50% | |
| 10 | MGX | Metagenomi Therapeutics INC | Stock-Other | 2.38% | +0.78% | — | |
| 11 | GOOG | Alphabet Inc-cl C | Stock-Comm Services | 2.29% | +0.89% | — | |
| 12 | OM | Outset Medical INC | Stock-Other | 2.15% | +0.99% | +1566.66% | |
| 13 | ADI | Analog Devices INC | Stock-Tech | 2.14% | +1.13% | — | |
| 14 | AAPL | Apple INC | Stock-Tech | 1.99% | +0.81% | — | |
| 15 | ASML | ASML Holding N.V. | Stock-Tech | 1.69% | +0.93% | — | |
| 16 | LIN | Linde plc | Stock-Materials | 1.67% | +0.87% | — | |
| 17 | AMZN | Amazon.com INC | Stock-Consumer Disc | 1.54% | +0.68% | +10.00% |
Performance for Q3 2026
+19.6%
Performance Last 4 Quarters
-4.7%
Based on 77% of reported portfolio value with available pricing
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 17 | $14.9M | 58 | |
| 2025-12-31 | 19 | $26.8M | 62 | |
| 2025-09-30 | 8 | $16.4M | 30 | |
| 2025-06-30 | 9 | $16.6M | 0 | |
| 2025-03-31 | 8 | $13.7M | 100 | |
| 2024-12-31 | 19 | $31.6M | 0 | |
| 2024-09-30 | 42 | $153.4M | 0 | |
| 2024-06-30 | 49 | $158.0M | 0 | |
| 2024-03-31 | 51 | $593.3M | 0 | |
| 2023-12-31 | 54 | $655.6M | 0 | |
| 2023-09-30 | 83 | $528.8M | 0 | |
| 2023-06-30 | 86 | $755.1M | 0 | 1464287278462F346090E |
| 2023-03-31 | 74 | $988.0M | 0 | 178462F2464287346090E |
| 2022-12-31 | 194 | $1.9B | 0 | 178462F246090E3464287 |
| 2022-09-30 | 197 | $1.7B | 0 | |
| 2022-06-30 | 203 | $1.7B | 0 | |
| 2022-03-31 | 226 | $3.1B | 0 | 1464287278462F378464A |
| 2021-12-31 | 231 | $2.8B | 0 | 178462F246090E3464287 |
| 2021-09-30 | 274 | $3.3B | 0 | 146090E278462F3464287 |
| 2021-06-30 | 216 | $3.2B | 100 | 178462F246090E3464287 |
| 2021-03-31 | 215 | $3.5B | 62 | |
| 2020-12-31 | 177 | $2.8B | 68 | |
| 2020-09-30 | 194 | $1.9B | 92 | |
| 2020-06-30 | 121 | $1.0B | 72 | |
| 2020-03-31 | 93 | $842.1M | 89 | |
| 2019-12-31 | 100 | $1.1B | 100 | |
| 2019-09-30 | 90 | $585.4M | 94 | |
| 2019-06-30 | 98 | $658.5M | 76 | |
| 2019-03-31 | 103 | $703.3M | 85 | |
| 2018-12-31 | 74 | $501.0M | 90 | |
| 2018-09-30 | 106 | $475.4M | 100 | |
| 2018-06-30 | 92 | $249.5M | 100 | |
| 2018-03-31 | 66 | $169.3M | 100 | |
| 2017-12-31 | 69 | $239.0M | 100 | |
| 2017-09-30 | 76 | $341.8M | 100 | |
| 2017-06-30 | 69 | $251.9M | 100 | |
| 2017-03-31 | 79 | $338.1M | 100 | |
| 2016-12-31 | 70 | $272.8M | 100 | |
| 2016-09-30 | 88 | $329.3M | 95 | |
| 2016-06-30 | 74 | $235.2M | 77 | |
| 2016-03-31 | 77 | $219.9M | 95 | |
| 2015-12-31 | 75 | $236.9M | 98 | |
| 2015-09-30 | 66 | $175.2M | 61 | |
| 2015-06-30 | 68 | $195.4M | 100 | |
| 2015-03-31 | 63 | $193.8M | 100 | |
| 2014-12-31 | 74 | $271.8M | — |
Pura Vida Investments, LLC's most significant position changes for 2026-03-31: Sold out: Danaher CORP (DHR); Add: Nvidia CORP (NVDA) — shares +7.30%; Add: Outset Medical INC (OM) — shares +1566.66%; Add: Amazon.com INC (AMZN) — shares +10.00%; Trim: Microsoft CORP (MSFT) — shares -17.50%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Establishment Labs Hldgs INC | +4.9% | — | Unchanged |
| 2 | NSPR | Inspiremd INC | +1.9% | — | Unchanged |
| 3 | CAI | Caris Life Sciences INC | +1.7% | — | Unchanged |
| 4 | NVDA | Nvidia CORP | +1.3% | +7.30% | Add |
| 5 | NTRA | Natera INC | +1.2% | — | Unchanged |
| 6 | ADI | Analog Devices INC | +1.1% | — | Unchanged |
| 7 | JPM | Jpmorgan Chase & Co | +1% | — | Unchanged |
| 8 | OM | Outset Medical INC | +1% | +1566.66% | Add |
| 9 | ASML | ASML Holding N.V. | +0.9% | — | Unchanged |
| 10 | GOOG | Alphabet Inc-cl C | +0.9% | — | Unchanged |
| 11 | LIN | Linde plc | +0.9% | — | Unchanged |
| 12 | AAPL | Apple INC | +0.8% | — | Unchanged |
| 13 | MGX | Metagenomi Therapeutics INC | +0.8% | — | Unchanged |
| 14 | AMZN | Amazon.com INC | +0.7% | +10.00% | Add |
| 15 | MSFT | Microsoft CORP | +0.3% | -17.50% | Trim |
| 16 | IMDX | Insight Molecular Diagnostic | -5.7% | — | Unchanged |
| 17 | BBNX | Beta Bionics INC | -13.1% | — | Unchanged |
| 18 | DHR | Danaher CORP | — | EXIT | Sold out |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-12 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-13 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-12 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-08-13 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-05-12 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-02-12 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-14 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-08-14 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-15 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-13 | 13F-HR | View on EDGAR |
| 2023-09-30 | 2023-11-14 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-08-14 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-05-15 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-02-14 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-15 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-16 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-14 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2021-11-15 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2021-08-16 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2021-05-12 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2021-02-16 | 13F-HR | View on EDGAR |
| 2020-09-30 | 2020-11-16 | 13F-HR | View on EDGAR |
| 2020-06-30 | 2021-02-12 | Amendment | View on EDGAR |
| 2020-06-30 | 2020-08-14 | 13F-HR | View on EDGAR |
| 2020-03-31 | 2021-02-12 | Amendment | View on EDGAR |
| 2020-03-31 | 2020-05-15 | 13F-HR | View on EDGAR |
| 2019-12-31 | 2021-02-12 | Amendment | View on EDGAR |
| 2019-12-31 | 2020-04-09 | Amendment | View on EDGAR |
| 2019-12-31 | 2020-02-14 | 13F-HR | View on EDGAR |
| 2019-09-30 | 2021-02-12 | Amendment | View on EDGAR |
| 2019-09-30 | 2019-11-14 | 13F-HR | View on EDGAR |
| 2019-06-30 | 2021-02-12 | Amendment | View on EDGAR |
| 2019-06-30 | 2019-08-14 | 13F-HR | View on EDGAR |
| 2019-03-31 | 2021-02-12 | Amendment | View on EDGAR |
| 2019-03-31 | 2019-05-14 | 13F-HR | View on EDGAR |
| 2018-12-31 | 2021-02-11 | Amendment | View on EDGAR |
| 2018-12-31 | 2019-02-14 | 13F-HR | View on EDGAR |
| 2018-09-30 | 2021-02-11 | Amendment | View on EDGAR |
| 2018-09-30 | 2018-11-14 | 13F-HR | View on EDGAR |
| 2018-06-30 | 2021-02-11 | Amendment | View on EDGAR |
| 2018-06-30 | 2018-08-14 | 13F-HR | View on EDGAR |
| 2018-03-31 | 2021-02-11 | Amendment | View on EDGAR |
| 2018-03-31 | 2018-08-13 | Amendment | View on EDGAR |
| 2018-03-31 | 2018-05-14 | 13F-HR | View on EDGAR |
| 2017-12-31 | 2021-02-11 | Amendment | View on EDGAR |
| 2017-12-31 | 2018-08-13 | Amendment | View on EDGAR |
| 2017-12-31 | 2018-02-14 | 13F-HR | View on EDGAR |
| 2017-09-30 | 2021-02-11 | Amendment | View on EDGAR |
| 2017-09-30 | 2018-08-13 | Amendment | View on EDGAR |
| 2017-09-30 | 2017-11-17 | Amendment | View on EDGAR |
| 2017-09-30 | 2017-11-17 | Amendment | View on EDGAR |
| 2017-09-30 | 2017-11-14 | 13F-HR | View on EDGAR |
| 2017-06-30 | 2017-08-14 | 13F-HR | View on EDGAR |
| 2017-03-31 | 2017-05-15 | 13F-HR | View on EDGAR |
| 2016-12-31 | 2017-02-14 | 13F-HR | View on EDGAR |
| 2016-09-30 | 2016-11-14 | 13F-HR | View on EDGAR |
| 2016-06-30 | 2016-08-15 | 13F-HR | View on EDGAR |
| 2016-03-31 | 2016-05-16 | 13F-HR | View on EDGAR |
| 2015-12-31 | 2016-02-16 | 13F-HR | View on EDGAR |
| 2015-09-30 | 2015-11-16 | 13F-HR | View on EDGAR |
| 2015-06-30 | 2015-08-14 | 13F-HR | View on EDGAR |
| 2015-03-31 | 2015-05-14 | 13F-HR | View on EDGAR |
| 2014-12-31 | 2015-02-17 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001698148
Total reported value
$14.7M
71 stks
2023-09-30
Stale — no recent filing
AUM within 0.9% of this institution
CIK 0001259927
Total reported value
$15.1M
9 stks
2025-09-30
Stale — no recent filing
AUM within 1.2% of this institution
CIK 0001282495
Total reported value
$14.7M
18 stks
2013-06-30
Stale — no recent filing
AUM within 1.4% of this institution
Institutions with overlapping top holdings
CIK 0001394517
Total reported value
$326.4M
1 stks
2026-03-31
1 of the top 5 holdings overlap, including Caris Life Sciences INC
CIK 0001423876
Total reported value
$642.4M
22 stks
2026-03-31
1 of the top 5 holdings overlap
CIK 0001549738
Total reported value
$243.5M
19 stks
2026-03-31
1 of the top 5 holdings overlap